HealthWatch, a global leading medical device company dedicated to securing personal health through comfortable, smart digital textile garments, has signed a strategic partnership with Nuveos Tech, an Indian technology innovation driven medical device distributor.
This is one of many partnerships HealthWatch has in development after its ongoing joint activity with Canadian company CardioComm. The agreement grants Nuveos commencement of a large-scale clinical trial at the H. N. Reliance Foundation Hospital, one of the leading hospital chains in India, with world-class healthcare services and cutting-edge technology. This clinical trial, run by Dr. Manoj Mashru, will lead to a future exclusive distribution agreement between HealthWatch and Nuveos.
Founded in 2010 in Kfar Saba, Israel, HealthWatch is known for its CE/FDA-approved Master Caution®, the first and only 3-12 lead ECG smart digital garment. It advocates a full management solution for the purpose of transforming healthcare, offering a digital health platform and virtual medical care intertwined with the Medical Internet-of-Things, said a press release.
“We will continue to invest in strategic alliances with well-positioned business partners to maintain our position as a front-runner in the smart clothes wearables industry globally,” said Dr. Gary Sagiv, CCO & EVP of HealthWatch. “This partnership with Nuveos demonstrates HealthWatch’s commitment and ability to be a global player in the rapidly expanding wearables global ecosystem. During the past decade, the Indian medical device market has proven to be the first to adopt innovative technologies, becoming a true global opinion leader. As HealthWatch’s main goal is to regain quality of life of cardiac patients, we believe that this step will contribute to the progress of the national healthcare system in India and to the well-being of patients. The current Indian economy is set to rapidly expand, which sets the HealthWatch-Nuvoos strategic partnership in an industry leading position to supply local demand.”
HealthWatch CEO Israel Schreiber expressed his enthusiasm about the joint venture. “Focusing on Israel as a source of innovative digital health tech products and solutions, Nuveos’ trust in HealthWatch is highly appreciated, being just the first step of a long-lasting relationship with Nuveos in particular and the Indian market, in general. The past few years’ tightening political and economic ties between Israel and India have made this collaboration possible. Nuveos were chosen out of many other distributors due to their professionalism, experience and enthusiasm to improve the medical system in India,” he said.
Recognized by the government of India, Nuveos Tech is a technology and innovation driven medical device startup providing affordable, accessible and quality healthcare service throughout India. Nuveos is a distribution, importing and marketing startup, forming strategic partnerships with medical devices company globally. The company’s goal is to bridge the gap between innovators and consumers – whether healthcare providers or patients.